Abstract
BRMS1 was discovered over a decade ago as a potential tumor suppressor gene. In this review, we summarize the recent findings about the structure of BRMS1, mechanisms of its action and a role of BRMS1 in the cancer progression. As a suppressor of metastasis, BRMS1 has demonstrated a variety of ways to act on the cell functions, such as cell migration, invasiveness, angiogenesis, cell survival, cytoskeleton rearrangements, cell adhesion, and immune recognition. This variety of effects is a likely reason behind the robustness of anti-metastatic influence of BRMS1. Intracellular signaling mechanisms employed by BRMS1 include regulation of transcription, EGF/HER2 signaling, and expression of NF-kB, fascin, osteopontin, and IL-6. Recently reported clinical studies confirm that BRMS1 can indeed be used as a prognostic marker. Approaches to employ BRMS1 in a development of anti-cancer treatment have also been made. The studies reviewed here with respect to BRMS1 structure, cellular effects, intracellular signaling, and clinical value consolidate the importance of BRMS1 in the development of metastasis.
Similar content being viewed by others
Abbreviations
- aa:
-
Amino acids
- NES:
-
Nuclear export signal
- NLS:
-
Nuclear localization signal
- NMR:
-
Nuclear-magnetic resonance
- EMT:
-
Epithelial-to-mesenchymal transition
References
Seraj, M. J., Samant, R. S., Verderame, M. F., & Welch, D. R. (2000). Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13. Cancer Research, 60(11), 2764–2769.
Samant, R. S., Seraj, M. J., Saunders, M. M., Sakamaki, T. S., Shevde, L. A., Harms, J. F., et al. (2000). Analysis of mechanisms underlying BRMS1 suppression of metastasis. Clinical and Experimental Metastasis, 18(8), 683–693.
Song, S., & Yuan, Y. (2013). The Drosophila ortholog of breast cancer metastasis suppresion gene, dBRMS1, is critical for developmental timing through regulating ecdysone signaling. Developmental Biology, 380(2), 344–350.
Hurst, D. R., Xie, Y., Edmonds, M. D., & Welch, D. R. (2009). Multiple forms of BRMS1 are differentially expressed in the MCF10 isogenic breast cancer progression model. Clinical and Experimental Metastasis, 26(2), 89–96.
Nikolaev, A. Y., Papanikolaou, N. A., Li, M., Qin, J., & Gu, W. (2004). Identification of a Nobel BRMS1-homologue protein p40 as a component of a mSin3A/p33(ING1b)/HDAC1 deacetylase complex. Biochemical and Biophysical Research Community, 323(4), 1216–1222.
Yang, J., Zhang, B., Lin, Y., Yang, Y., Liu, X., & Lu, F. (2008). Breast cancer metastasis suppressor 1 inhibits SDF-1alpha-induced migration of non-small cell lung cancer by decreasing CXCR4 expression. Cancer Letters, 269(1), 46–56.
Zhang, S., Lin, Q. D., & DI, W. (2006). Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1. International Journal of Gynecological Cancer, 16(2), 522–531.
Slipicevic, A., Holm, R., Emilsen, E., Ree Rosnes, A. K., Welch, D. R., Mælandsmo, G. M., et al. (2012). Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival. BMC Cancer. doi:10.1186/1471-2407-12-73.
Zhang, Y., Guan, J., Sun, Y., Chai, J., Zou, T., Gong, W., et al. (2014). Effect of BRMS1 on tumorigenicity and metastasis of human rectal cancer. Cell Biochemistry and Biophysics, 70(1), 505–509.
Spínola-Amilibia, M., Rivera, J., Ortiz-Lombardía, M., Romero, A., Neira, J. L., & Bravo, J. (2011). The structure of BRMS1 nuclear export signal and SNX6 interacting region reveals a hexamer formed by antiparallel coiled coils. Journal of Molecular Biology, 411(5), 1114–1127.
Hurst, D. R., Xie, Y., Vaidya, K. S., Mehta, A., Moore, B. P., Accavitti-Loper, M. A., et al. (2008). Alterations of BRMS1-ARID4A interaction modify gene expression but still suppress metastasis in human breast cancer cells. Journal of Biological Chemistry, 283(12), 7438–7444.
Wu, J., Wang, Y., Qiao, X., Saiyin, H., Zhao, S., Qiao, S., et al. (2013). Cloning and characterization of a novel human BRMS1 transcript variant in hepatocellular carcinoma cells. Cancer Letters, 337(2), 266–275.
Zhang, Y., Ye, L., Tan, Y., Sun, P., Ji, K., & Jiang, W. G. (2014). Expression of breast cancer metastasis suppressor-1, BRMS-1, in human breast cancer and the biological impact of BRMS-1 on the migration of breast cancer cells. Journal Anticancer Research, 34(3), 1417–1426.
Mei, P., Bai, J., & Zheng, J. (2014). BRMS1 suppresses glioma progression by regulating invasion, migration and adhesion of glioma cells. PLoS One. doi:10.1371/journal.pone.0098544.
Phadke, P. A., Vaidya, K. S., Nash, K. T., Hurst, D. R., & Welch, D. R. (2008). BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process. American Journal of Pathology, 172(3), 809–817.
Samant, R. S., Debies, M. T., Hurst, D. R., Moore, B. P., Shevde, L. A., & Welch, D. R. (2006). Suppression of murine mammary carcinoma metastasis by the murine ortholog of breast cancer metastasis suppressor 1 (Brms1). Cancer Letters, 235(2), 260–265.
Li, J., & Li, G. (2010). Cell cycle regulator ING4 is a suppressor of melanoma angiogenesis that is regulated by the metastasis suppressor BRMS1. Cancer Research, 70(24), 10445–10453.
Hedley, B. D., Vaidya, K. S., Phadke, P., MacKenzie, L., Dales, D. W., & Postenka, C. O. (2008). BRMS1 suppresses breast cancer metastasis in multiple experimental models of metastasis by reducing solitary cell survival and inhibiting growth initiation. Clinical and Experimental Metastasis, 25(7), 727–740.
Wu, Y., Jiang, W., Wang, Y., Wu, J., Saiyin, H., Qiao, X., et al. (2012). Breast cancer metastasis suppressor 1 regulates hepatocellular carcinoma cell apoptosis via suppressing osteopontin expression. PLoS One. doi:10.1371/journal.pone.0042976.
You, J., He, X., Ding, H., & Zhang, T. (2014). BRMS1 regulates apoptosis in non-small cell lung cancer cells. Cell Biochemistry and Biophysics. doi:10.1007/s12013-014-0226-8.
Liu, Y., Smith, P. W., & Jones, D. R. (2006). Breast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA/p65 and promoting apoptosis. Molecular and Cellular Biology, 26(23), 8683–8696.
Wu, Y., McEwen, G. D., Harihar, S., Baker, S. M., DeWald, D. B., & Zhou, A. (2010). BRMS1 expression alters the ultrastructural, biomechanical and biochemical properties of MDA-MB-435 human breast carcinoma cells: an AFM and Raman microspectroscopy study. Cancer Letters, 293(1), 82–91.
Khotskaya, Y. B., Beck, B. H., Hurst, D. R., Han, Z., Xia, W., Hung, M. C., et al. (2014). Expression of metastasis suppressor BRMS1 in breast cancer cells results in a marked delay in cellular adhesion to matrix. Molecular Carcinogenesis, 53(12), 1011–1026.
Vaidya, K. S., Harihar, S., Phadke, P., Stafford, L. J., Hurst, D., Hicks, D. G., et al. (2008). Breast cancer metastasis suppressor-1 differentially modulates growth factor signaling. Journal of Biological Chemistry, 283(42), 28354–28360.
Saunders, M. M., Seraj, M. J., Li, Z., Zhou, Z., Winter, C. R., Welch, D. R., et al. (2001). Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication. Cancer Research, 61(5), 1765–1767.
Shevde, L. A., Samant, R. S., Goldberg, S. F., Sikaneta, T., Alessandrini, A., Donahue, H. J., et al. (2002). Suppression of human melanoma metastasis by the metastasis suppressor gene, BRMS1. Experimental Cell Research, 273(2), 229–239.
Meehan, W. J., & Welch, D. R. (2003). Breast cancer metastasis suppressor 1: update. Clinical and Experimental Metastasis, 20(1), 45–50.
Kapoor, P., Saunders, M. M., Li, Z., Zhou, Z., Sheaffer, N., & Kunze, E. L. (2004). Breast cancer metastatic potential: correlation with increased heterotypic gap junctional intercellular communication between breast cancer cells and osteoblastic cells. International Journal of Cancer, 111(5), 693–697.
Jiang, J., Xia, M., Feng, J. B., & Kong, B. H. (2007). Inhibitory effect of breast cancer metastasis suppressor l gene on metastasis of human ovarian cancer cell in vitro and in vivo. Zhonghua Fu Chan Ke Za Zhi, 42(6), 398–402.
Hall, E. H., Liu, Y., Xiao, A., Shock, L., Brautigan, D. L., & Mayo, M. W. (2014). Inhibition of breast cancer metastasis suppressor 1 promotes a mesenchymal phenotype in lung epithelial cells that express oncogenic K-RasV12 and loss of p53. PLoS One. doi:10.1371/journal.pone.0095869.
Liu, Y., Mayo, M. W., Xiao, A., Hall, E. H., Amin, E. B., & Kadota, K. (2015). Loss of BRMS1 promotes a mesenchymal phenotype through NF-κB-dependent regulation of twist 1. Molecular and Cellular Biology, 35(1), 303–317.
Champine, P. J., Michaelson, J., Weimer, B. C., Welch, D. R., & DeWald, D. B. (2007). Microarray analysis reveals potential mechanisms of BRMS1-mediated metastasis suppression. Clinical and Experimental Metastasis, 24(7), 551–565.
Hurst, D. R. (2012). Metastasis suppression by BRMS1 associated with SIN3 chromatin remodeling complexes. Cancer Metastasis Reviews, 31(3–4), 641–651.
Meehan, W. J., Samant, R. S., Hopper, J. E., Carrozza, M. J., Shevde, L. A., Workman, J. L., et al. (2004). Breast cancer metastasis suppressor 1 (BRMS1) forms complexes with retinoblastoma-binding protein 1 (RBP1) and the mSin3 histone deacetylase complex and represses transcription. Journal of Biological Chemistry, 279(2), 1562–1569.
Cui, R. X., Liu, N., He, Q. M., Li, W. F., Huang, B. J., Sun, Y., et al. (2012). Low BRMS1 expression promotes nasopharyngeal carcinoma metastasis in vitro and in vivo and is associated with poor patient survival. BMC Cancer. doi:10.1186/1471-2407-12-376.
Chimonidou, M., Strati, A., Tzitzira, A., Sotiropoulou, G., Malamos, N., Georgoulias, V., et al. (2011). DNA methylation of tumor suppressor and metastasis suppressor genes in circulating tumor cells. Clinical Chemistry, 57(8), 1169–1177.
Li, J., Cheng, Y., Tai, D., Martinka, M., Welch, D. R., & Li, G. (2011). Prognostic significance of BRMS1 expression in human melanoma and its role in tumor angiogenesis. Oncogene, 30(8), 896–906.
Cicek, M., Fukuyama, R., Welch, D. R., Sizemore, N., & Casey, G. (2005). Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity. Cancer Research, 65(9), 3586–3595.
Sheng, X. J., Zhou, D. M., Liu, Q., Lou, S. Y., Song, Q. Y., & Zhou, Y. Q. (2014). BRMS1 inhibits expression of NF-kappaB subunit p65, uPA and OPN in ovarian cancer cells. European Journal of Gynaecological Oncology, 35(3), 236–242.
Hurst, D. R., Edmonds, M. D., Scott, G. K., Benz, C. C., Vaidya, K. S., & Welch, D. R. (2009). Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Research, 69(4), 1279–1283.
Hicks, D., Yoder, B. J., Short, S., Tarr, S., Prescott, N., Crowe, J. P., et al. (2006). Loss of breast cancer metastasis suppressor 1 protein expression predicts reduced disease-free survival in some breast cancer patients. Clinical Cancer Research, 12(22), 6702–6708.
Al-Alwan, M., Olabi, S., Ghebeh, H., Barhoush, E., Tulbah, A., Al-Tweigeri, T., et al. (2011). Fascin is a key regulator of breast cancer invasion that acts via the modification of metastasis-associated molecules. PLoS One. doi:10.1371/journal.pone.0027339.
Rivera, J., Megías, D., & Bravo, J. (2010). Sorting nexin 6 interacts with breast cancer metastasis suppressor-1 and promotes transcriptional repression. Journal of Cellular Biochemistry, 111(6), 1464–1472.
Hedley, B. D., Welch, D. R., Allan, A. L., Al-Katib, W., Dales, D. W., Postenka, C. O., et al. (2008). Downregulation of osteopontin contributes to metastasis suppression by breast cancer metastasis suppressor 1. International Journal of Cancer, 123(3), 526–534.
Metge, B. J., Liu, S., Riker, A. I., Fodstad, O., Samant, R. S., & Shevde, L. A. (2010). Elevated osteopontin levels in metastatic melanoma correlate with epigenetic silencing of breast cancer metastasis suppressor 1. Oncology, 78(1), 75–86.
Samant, R. S., Clark, D. W., Fillmore, R. A., Cicek, M., Metge, B. J., Chandramouli, K. H., et al. (2007). Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-kappaB activation. Molecular Cancer. doi:10.1186/1476-4598-6-6.
Rivera, J., Megias, D., & Bravo, J. (2007). Proteomics-based strategy to delineate the molecular mechanisms of the metastasis suppressor gene BRMS1. Journal of Proteome Research, 6(10), 4006–4018.
Zhang, Y., Chin-Quee, K., Riddle, R. C., Li, Z., Zhou, Z., & Donahue, H. J. (2013). BRMS1 sensitizes breast cancer cells to ATP-induced growth suppression. Bioresource Open Access, 2(2), 77–83.
Liu, Y., Mayo, M. W., Nagji, A. S., Hall, E. H., Shock, L. S., Xiao, A., et al. (2013). BRMS1 suppresses lung cancer metastasis through an E3 ligase function on his tone acetyltransferase p300. Cancer Research, 73(4), 1308–1317.
Metge, B. J., Frost, A. R., King, J. A., Dyess, D. L., Welch, D. R., Samant, R. S., et al. (2008). Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer. Clinical and Experimental Metastasis, 25(7), 753–763.
Szarc vel Szic, K., Op de Beeck, K., Ratman, D., Wouters, A., Beck, I. M., Declerck, K., et al. (2014). Pharmacological levels of Withaferin A (Withania somnifera) trigger clinically relevant anticancer effects specific to triple negative breast cancer cells. PLoS One. doi:10.1371/journal.pone.0087850.
Zhang, Z., Yamashita, H., Toyama, T., Yamamoto, Y., Kawasoe, T., & Iwase, H. (2006). Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer. Clinical Cancer Research, 12(21), 6410–6414.
Stark, A. M., Tongers, K., & Maass, N. (2005). Reduced metastasis-suppressor gene mRNA expression in breast cancer metastases. Journal of Cancer Research and Clinical Oncology, 131(3), 191–198.
Yang, J., Shen, Y., Liu, B., & Tong, Y. (2011). Promoter methylation of BRMS1 correlates with smoking history and poor survival in non-small cell lung cancer patients. Lung Cancer, 74(2), 305–309.
Smith, J., Naseem, R., & Webb, M. (2009). Purification and characterisation of the breast cancer metastasis suppressor, BRMS1. Protein Expression and Purification, 67(2), 70–75.
Li, J., Zhang, Z., & Li, G. (2011). Patient outcome prediction using multiple biomarkers in human melanoma: a clinicopathological study of 118 cases. Experimental Therapeutics Medicine, 2(1), 131–135.
Chimonidou, M., Kallergi, G., Georgoulias, V., Welch, D. R., & Lianidou, E. S. (2013). Breast cancer metastasis suppressor-1 promoter methylation in primary breast tumors and corresponding circulating tumor cells. Molecular Cancer Research, 11(10), 1248–1257.
Balgkouranidou, I., Chimonidou, M., Milaki, G., Tsarouxa, E. G., Kakolyris, S., Welch, D. R., et al. (2014). Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer. British Journal Cancer, 110(8), 2054–2062.
Nagji, A. S., Liu, Y., Stelow, E. B., Stukenborg, G. J., & Jones, D. R. (2010). BRMS1 transcriptional repression correlates with CpG island methylation and advanced pathological stage in non-small cell lung cancer. Journal of Pathology, 221(2), 229–237.
Kelly, L. M., Buggy, Y., Hill, A., O’Donovan, N., Duggan, C., McDermott, E. W., et al. (2005). Expression of the breast cancer metastasis suppressor gene, BRMS1, in human breast carcinoma: lack of correlation with metastasis to axillary lymph nodes. Tumour Biology, 26(4), 213–216.
Cook, L. M., Cao, X., Dowell, A. E., Debies, M. T., Edmonds, M. D., Beck, B. H., et al. (2012). Ubiquitous Brms1 expression is critical for mammary carcinoma metastasis suppression via promotion of apoptosis. Clinical and Experimental Metastasis, 29(4), 315–325.
Rivera, J., Megías, D., Navas, C., & Bravo, J. (2009). Identification of essential sequences for cellular localization in BRMS1 metastasis suppressor. PLoS One. doi:10.1371/journal.pone.0006433.
Riker, A., & Samant, R. S. (2012). Location, location, location: the BRMS1 protein and melanoma progression. BMC Medicine. doi:10.1186/1741-7015-10-19.
Frolova, N., Edmonds, M. D., Bodenstine, T. M., Seitz, R., Johnson, M. R., Feng, R., et al. (2009). A shift from nuclear to cytoplasmic breast cancer metastasis suppressor 1 expression is associated with highly proliferative estrogen receptor-negative breast cancers. Tumour Biology, 30(3), 148–159.
Hurst, D. R., Xie, Y., Thomas, J. W., Liu, J., Edmonds, M. D., Stewart, M. D., et al. (2013). The C-terminal putative nuclear localization sequence of breast cancer metastasis suppressor 1, BRMS1, is necessary for metastasis suppression. PLoS One. doi:10.1371/journal.pone.0055966.
Gomez, H., Neciosup, S., Tosello, C., Mano, M., Bines, J., Ismael, G., et al. (2012). A randomized open-label, phase ii study of lapatinib-capecitabine or lapatinib-vinorelbine or lapatinib/gemcitabine in subjects with Her2/neu amplified metastatic breast cancer patients progression after taxanes treatment, 2012 ASCO Annual Meeting Proceedings, Abstract No: e11087, Study ID: GLICO-0801.
Acknowledgments
This work was supported in part by “Oves Minnesfond” and Radiumhemmets Research Funds (#121202) to S.S.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kodura, M.A., Souchelnytskyi, S. Breast carcinoma metastasis suppressor gene 1 (BRMS1): update on its role as the suppressor of cancer metastases. Cancer Metastasis Rev 34, 611–618 (2015). https://doi.org/10.1007/s10555-015-9583-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10555-015-9583-z